BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Deals

  Orgenesis completes sale of Masthercell subsidiary; receives approximately USD 127 million in net proceeds

  Sale reflects culmination of successful CDMO strategy initiated in 2015 and 59 percent 5-year CAGR of Masthercell under Orgenesis’ leadership

  February 14, 2020

   · 

  5 min read
• 

  Policy

  Eisai’s Weight Loss Drug Belviq Pulled From Market Over Cancer Risk

  Eisai indicated it was voluntarily withdrawing the drug, but in a statement noted it disagreed with the FDA’s interpretation of the data and believes the drug’s benefits outweigh the cancer risk.

  February 14, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  BioCapital

  Clinical Catch-Up: February 10-14

  It was a very busy week for clinical trial news. Here’s a look.

  February 14, 2020

   · 

  11 min read

   · 

  Mark Terry
• 

  Genetown

  Dana-Farber Researchers Present Promising Kidney Cancer Trial Results

  The study was in 55 patients who had an average of three previous treatment regimens. The results are promising enough that a Phase III trial is planned.

  February 14, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Scientists develop non-invasive method to predict onset of dementia

  Screening using EMR data could help with early identification of Alzheimer’s disease risk

  February 14, 2020

   · 

  6 min read
• Business

  Calliditas Therapeutics - Year-End Report 2019

  In the last quarter of 2019, we achieved a major milestone: the full recruitment of 200 patients for Part A of our pivotal Phase 3 study, NefIgArd.

  February 14, 2020

   · 

  3 min read
• Business

  Year-End Report 1 January - 31 December 2019

  We summarize 2019 and note that: RaySearch continues to develop at a rapid pace.

  February 14, 2020

   · 

  3 min read
• Business

  IRRAS AB Publishes Interim Report for the Period January to December 2019

  The fourth quarter of 2019 was an important period of progress for IRRAS.

  February 14, 2020

   · 

  4 min read
• Nobio Antibacterial Breakthrough Technology to Be Featured on Worldwide Business With kathy ireland® This Sunday, Feb 16, 5:30pm EST

  Nobio is pleased to announce that Worldwide Business with kathy ireland® is schedule to air an exclusive interview with Nobio CEO Yoram Ashery and other prominent figures on Fox Business Network on Sunday, February 16, 2020 at 5:30pm EST as sponsored content.

  February 14, 2020

   · 

  2 min read
• Business

  Fennec Provides Business Update and Announces Fiscal Year 2019 Financial Results

  NDA (New Drug Application) and Marketing Authorization Application (MAA) completed in February 2020

  February 14, 2020

   · 

  8 min read